Search - tctmd.com

Displaying 1 - 20 of 322

Sort: Relevancy | Date

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

Presentation TCT 2025

TCT 566: Prognostic Significance of Coronary Microvascular Dysfunction for Long-term Adverse Outcomes in Hypertrophic Cardiomyopathy Patients

Presenter: Jingpu Wang

October 28, 2025

Presentation TCT 2025

TCT 564: Efficacy and Safety of Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy – An Updated Meta-Analysis of Randomized Controlled Trials

Presenter: Prakash Upreti

October 28, 2025

Presentation TCT 2025

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

Presenter: Jorrian Abadeer

October 28, 2025

Presentation TCT 2025

TCT 563: Comparative Outcomes of Mavacamten with AV Nodal Blockers vs. AV Nodal Blockers Alone in Patients with Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Presenter: Aditya Desai

October 28, 2025

Presentation TCT 2025

TCT 568: Safety and Long-Term Efficacy of First Septal Coil Embolization in Patients with Hypertrophic Obstructive Cardiomyopathy

Presenter: Melissa McCormack

October 28, 2025

Presentation TCT 2025

TCT 1270: Impact of Frailty on Patients Undergoing TEER MitraClip With Underlying Hypertrophic Cardiomyopathy

Presenter: Prakash Upreti

October 27, 2025

Presentation TCT 2025

TCT 562: Prognostic and Procedural Impact of Coexistent Aortic Stenosis in Hypertrophic Cardiomyopathy: A Propensity-Matched Cohort Study

Presenter: Usman Akbar

October 27, 2025

Presentation TCT 2025

TCT 559: TRANScatheter edge to edge rePAir for systolic anterior motion related mitral REgurgitation in patieNTs with hypertrophic cardiomyopathy. The TRANSPARENT international registry.

Presenter: Luca Arzuffi

October 27, 2025

Presentation TCT 2025

TCT 556: Fibromuscular Subaortic Stenosis Misdiagnosed as Dynamic Left Ventricular Outflow Obstruction due to Hypertrophic Cardiomyopathy: A Systematic Review of Reported Clinical Cases

Presenter: Harris Majeed

October 26, 2025

Presentation TCT 2025

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Presenter: Puneet Aggarwal

October 25, 2025

Presentation TCT 2025

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

Presenter: Toby Rogers

October 25, 2025

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

AI Model Saves Time, Increases Accuracy of Echo Measurements

Yael L. Maxwell

September 22, 2025

News Conference News ESC 2025

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

L.A. McKeown

September 09, 2025

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

Presentation ESC 2025

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Presenter: Milind Y Desai

August 30, 2025

News Conference News ESC 2025

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

Caitlin E. Cox

August 30, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

Advertisement

What’s Going to Be Hot at AHA 2025?

TCT 566: Prognostic Significance of Coronary Microvascular Dysfunction for Long-term Adverse Outcomes in Hypertrophic Cardiomyopathy Patients

TCT 564: Efficacy and Safety of Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy – An Updated Meta-Analysis of Randomized Controlled Trials

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

TCT 563: Comparative Outcomes of Mavacamten with AV Nodal Blockers vs. AV Nodal Blockers Alone in Patients with Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

TCT 568: Safety and Long-Term Efficacy of First Septal Coil Embolization in Patients with Hypertrophic Obstructive Cardiomyopathy

TCT 1270: Impact of Frailty on Patients Undergoing TEER MitraClip With Underlying Hypertrophic Cardiomyopathy

TCT 562: Prognostic and Procedural Impact of Coexistent Aortic Stenosis in Hypertrophic Cardiomyopathy: A Propensity-Matched Cohort Study

TCT 559: TRANScatheter edge to edge rePAir for systolic anterior motion related mitral REgurgitation in patieNTs with hypertrophic cardiomyopathy. The TRANSPARENT international registry.

TCT 556: Fibromuscular Subaortic Stenosis Misdiagnosed as Dynamic Left Ventricular Outflow Obstruction due to Hypertrophic Cardiomyopathy: A Systematic Review of Reported Clinical Cases

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

CVD Still the Leading Cause of Death and Disease Globally

AI Model Saves Time, Increases Accuracy of Echo Measurements

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

What’s Going to Be Hot at ESC Congress 2025?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content